LANSDALE HOSPITAL — History
CCN 390012 | 3-year financial timeline | COVID resilience: 49/100
🛡️ Public data only — no PHI permitted on this instance.
$94M
Latest Revenue (FY2022)
+2.9%
Revenue CAGR (3yr)
2.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $89M | $91M | $94M | +2.9% | +2.9% |
| Operating Expenses | $84M | $85M | $91M | +7.1% | +4.3% |
| Operating Margin | 5.4% | 6.5% | 2.8% | -57.9% | -28.6% |
| Net Income | $5M | $6M | $3M | -56.6% | -26.6% |
| Licensed Beds | 140 | 140 | 140 | +0.0% | +0.0% |
| Total Patient Days | 23,690 | 24,322 | 24,913 | +2.4% | +2.5% |
| Medicare Day % | 40% | 46% | 44% | -3.6% | +4.8% |
| Medicaid Day % | 3% | 2% | 1% | -12.7% | -27.3% |
COVID Impact & Recovery
Resilience Score: 49/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +5.9% ($89M → $94M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+2.9%
This Hospital
+7.6%
State Avg
Latest Margin
2.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $97M | 1.4% |
| FY2024 (proj) | $99M | 0.1% |
| FY2025 (proj) | $102M | -1.2% |